RAUMEDIC
RAUMEDIC AG, headquartered in Germany, is a leading player in the medical technology industry, specialising in the development and production of high-quality polymer solutions for medical applications. Founded in 1949, the company has established a strong presence in Europe and North America, focusing on critical areas such as catheter systems, tubing, and custom medical devices. With a commitment to innovation, RAUMEDIC stands out for its advanced manufacturing processes and expertise in biocompatible materials. The company’s core products are designed to meet stringent regulatory standards, ensuring safety and reliability in healthcare settings. RAUMEDIC has achieved notable milestones, including certifications that underscore its dedication to quality and excellence in the medical field. As a trusted partner for healthcare providers, RAUMEDIC continues to enhance patient care through its cutting-edge solutions.
DitchCarbon Score
How does RAUMEDIC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RAUMEDIC's score of 33 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RAUMEDIC's reported carbon emissions
In 2023, RAUMEDIC reported total carbon emissions of approximately 68,034 kg CO2e globally, with specific emissions of 2,499,000 kg CO2e from Scope 1, 6,835 kg CO2e from Scope 2, and 58,700 kg CO2e from Scope 3. In Germany, the company’s emissions were about 6,835 kg CO2e for Scope 2 and 58,700 kg CO2e for Scope 3. Comparatively, in 2022, RAUMEDIC's global emissions totalled approximately 85,444 kg CO2e, with Scope 1 emissions at 2,329,000 kg CO2e, Scope 2 at 6,583.8 kg CO2e, and Scope 3 at 75,444 kg CO2e. The German figures for 2022 showed Scope 2 emissions of about 7,148 kg CO2e and Scope 3 emissions of 75,444 kg CO2e. RAUMEDIC has not disclosed specific reduction targets or initiatives as part of their climate commitments. The emissions data is cascaded from their parent company, Raumedic AG, which is part of a corporate family relationship with REHAU Industries SE & Co. KG, indicating a structured approach to sustainability reporting. Overall, RAUMEDIC is actively monitoring its carbon footprint, focusing on transparency in emissions reporting, although specific reduction strategies have not been outlined.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 2,329,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 7,148,000 | 0,000.0 | 0,000 |
| Scope 3 | 75,444,000 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RAUMEDIC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
